How chronic musculoskeletal pain opens the door to opioid dependency
As employers grapple with addressing opioid misuse, experts have identified flawed chronic musculoskeletal (MSK) pain management as a key contributor.

Most large employers are acutely aware of their opioid problem, but what they may be less aware of is the pathway that leads workers to opioid misuse: chronic MSK pain, like joint and back pain.
When people seek relief from chronic MSK pain, they often receive opioid painkillers, either as first-line treatment or after surgery. Surgery for MSK pain has been shown to play a role in the opioid crisis — both because opioids are often prescribed after MSK surgeries, and because these patients are uniquely susceptible to dependency.¹
Opioid use comes at a cost.
Opioid Misuse Can Be Avoided
Evidence-based clinical practice guidelines recommend patients first try non-drug therapy — such as exercise, education, and behavioral health — for chronic MSK pain. However, many employees report that they do not have the time or know-how to pursue these treatments. So what can you do to help? Empower your members to overcome barriers to following evidence-based MSK care by implementing a comprehensive digital care program, like Hinge Health.

Download the full report
Empower your workforce to avoid opioid misuse by making non-invasive, and non-addictive, care available.
- 1Saigal AN, Jones HM. Interdisciplinary Mitigation of Opioid Misuse in Musculoskeletal Patients. HSS J. 2019 Feb;15(1):72-75. doi: 10.1007/s11420-018-09656-w
- 2Berardino K, Carroll AH, Kaneb A, Civilette MD, Sherman WF, Kaye AD. An Update on Postoperative Opioid Use and Alternative Pain Control Following Spine Surgery. Orthop Rev (Pavia). 2021 Jun 22;13(2):24978. doi: 10.52965/001c.24978
- 3National Safety Council. Poll: 75% of Employers Say Their Workplace Impacted by Opioid Use. March 19, 2019
- 42023 Hinge Health book of business claims data analysis based on a random sample of 5 million commercially insured population.


